(Q34145598)

English

Medium-dose riboflavin as a prophylactic agent in children with migraine: a preliminary placebo-controlled, randomised, double-blind, cross-over trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Medium-dose riboflavin as a prophylactic agent in children with migraine: a preliminary placebo-controlled, randomised, double-blind, cross-over trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

Jacques Bruijn

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Hugo Duivenvoorden

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Jan Passchier

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Natascha Dijkstra

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Willem-Frans Arts

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

language of work or name

0 references

publication date

26 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1426-1434

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Symptomatic treatment of migraine in children: a systematic review of medication trials

1 reference

https://api.crossref.org/works/10.1177%2F0333102410365106

21 January 2018

Prophylactic treatment of migraine in children. Part 1. A systematic review of non-pharmacological trials

1 reference

https://api.crossref.org/works/10.1177%2F0333102410365106

21 January 2018

Prophylactic treatment of migraine in children. Part 2. A systematic review of pharmacological trials

1 reference

https://api.crossref.org/works/10.1177%2F0333102410365106

21 January 2018

Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society.

1 reference

https://api.crossref.org/works/10.1177%2F0333102410365106

21 January 2018

Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age.

1 reference

https://api.crossref.org/works/10.1177%2F0333102410365106

21 January 2018

Abnormal brain and muscle energy metabolism shown by 31P magnetic resonance spectroscopy in patients affected by migraine with aura

1 reference

https://api.crossref.org/works/10.1177%2F0333102410365106

21 January 2018

31P-magnetic resonance spectroscopy in migraine without aura

1 reference

https://api.crossref.org/works/10.1177%2F0333102410365106

21 January 2018

Effect of high-dose vitamins, coenzyme Q and high-fat diet in paediatric patients with mitochondrial diseases

1 reference

https://api.crossref.org/works/10.1177%2F0333102410365106

21 January 2018

High-dose riboflavin as a prophylactic treatment of migraine: results of an open pilot study.

1 reference

https://api.crossref.org/works/10.1177%2F0333102410365106

21 January 2018

Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F0333102410365106

21 January 2018

High-dose riboflavin treatment is efficacious in migraine prophylaxis: an open study in a tertiary care centre

1 reference

https://api.crossref.org/works/10.1177%2F0333102410365106

21 January 2018

Chronic nonprogressive headaches in children and adolescents

1 reference

https://api.crossref.org/works/10.1177%2F0333102410365106

21 January 2018

High-dose riboflavin for migraine prophylaxis in children: a double-blind, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F0333102410365106

21 January 2018

A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial

1 reference

https://api.crossref.org/works/10.1177%2F0333102410365106

21 January 2018

Placebo efficacy in childhood and adolescence migraine: an analysis of double-blind and placebo-controlled studies

1 reference

https://api.crossref.org/works/10.1177%2F0333102410365106

21 January 2018

Mitochondrial DNA haplogroups influence the therapeutic response to riboflavin in migraineurs.

1 reference

https://api.crossref.org/works/10.1177%2F0333102410365106

21 January 2018

Riboflavin prophylaxis in pediatric and adolescent migraine

1 reference

https://api.crossref.org/works/10.1177%2F0333102410365106

21 January 2018

Quality of life in children with primary headache in a general hospital

1 reference

https://api.crossref.org/works/10.1177%2F0333102410365106

21 January 2018

Diagnostic lessons from the spectrum study

1 reference

https://api.crossref.org/works/10.1177%2F0333102410365106

21 January 2018

Identifiers

10.1177/0333102410365106

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34145598&oldid=1965710512"